Status:
NOT_YET_RECRUITING
Eating Disorder Chatbot Optimization
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
New York University
University of South Carolina
Conditions:
Eating Disorders
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to optimize an automated digital chatbot intervention for adults with clinical or subclinical eating disorders.
Detailed Description
Eating disorders (EDs) are common-affecting an estimated 10% of individuals in their lifetimes-and have disabling consequences being associated with high psychiatric comorbidity, impairment, and morta...
Eligibility Criteria
Inclusion
- 18+ years old
- Owns a smartphone
- Speaks English
- US resident
- Screens for a clinical or subclinical eating disorder
- Low suicidality
- Not currently in treatment for an eating disorder
- Does not have a medical condition or take medications that impact appetite/weight
- Not currently pregnant
Exclusion
- Below 18 years of age
- Does not own a smartphone
- Does not speak English
- Lives outside the US
- Screens as: at risk for an eating disorder, anorexia nervosa, atypical anorexia nervosa, avoidant/restrictive food intake disorder, or not at risk for an ED
- High suicidality
- In treatment for an eating disorder
- Has a medical condition or takes medication(s) that impact appetite/weight
- Currently pregnant
Key Trial Info
Start Date :
March 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2029
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT07218302
Start Date
March 1 2026
End Date
July 31 2029
Last Update
October 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University in St. Louis
St Louis, Missouri, United States, 63105